SOPH
Sophia Genetics SANASDAQHEALTHCAREHEALTH INFORMATION SERVICES
Key Statistics
Market Cap
$350.34M
P/E Ratio
—
EPS
$-1.18
Beta
1.01
52W High
$5.70
52W Low
$2.59
50-Day MA
$4.94
200-Day MA
$4.51
Dividend Yield
—
Profit Margin
-99.70%
Forward P/E
—
PEG Ratio
—
About Sophia Genetics SA
Sophia Genetics SA (SOPH) is a pioneering company at the forefront of data-driven medicine, focusing on enhancing patient outcomes through advanced genomic and clinical data analytics. Utilizing cutting-edge machine learning technologies, the firm provides a comprehensive platform that enables healthcare providers to interpret complex genomic data, facilitating tailored treatment strategies in oncology, rare diseases, and hereditary conditions. With a robust global footprint and strategic partnerships with prominent healthcare organizations, Sophia Genetics is committed to transforming the landscape of precision medicine, solidifying its position as a leading entity in the genomics industry.
Fundamentals
| Revenue (TTM) | $81.18M |
| Gross Profit (TTM) | $54.62M |
| EBITDA | $-70.32M |
| Operating Margin | -79.70% |
| Return on Equity | -123.30% |
| Return on Assets | -29.70% |
| Revenue/Share (TTM) | $1.18 |
| Book Value | $0.64 |
| Price-to-Book | 7.70 |
| Price-to-Sales (TTM) | 4.32 |
| EV/Revenue | 4.297 |
| EV/EBITDA | -0.30 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 22.00% |
| Shares Outstanding | $71.79M |
| Float | $51.73M |
| % Insiders | 8.30% |
| % Institutions | 55.96% |
Historical Volatility
HV 10-Day
62.78%
HV 20-Day
61.09%
HV 30-Day
54.61%
HV 60-Day
54.30%
HV Rank
45.6%
Volatility is currently expanding
Analyst Ratings
Consensus ($8.00 target)
4
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026